The store will not work correctly when cookies are disabled.
N-(2-(1,6,7-trimethyl-1H-indol-3-yl)ethyl)acetamide
ID: ALA4088981
PubChem CID: 137644672
Max Phase: Preclinical
Molecular Formula: C15H20N2O
Molecular Weight: 244.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)NCCc1cn(C)c2c(C)c(C)ccc12
Standard InChI: InChI=1S/C15H20N2O/c1-10-5-6-14-13(7-8-16-12(3)18)9-17(4)15(14)11(10)2/h5-6,9H,7-8H2,1-4H3,(H,16,18)
Standard InChI Key: PCWULMBOBVYXJA-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
13.0214 -10.1901 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2372 -9.1170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5043 -9.5133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0173 -8.8570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2414 -9.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1098 -6.9503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5232 -8.7085 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6587 -7.5570 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.5315 -10.3511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3091 -7.1236 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8257 -9.1170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8175 -9.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0615 -7.9036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2649 -8.0770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3574 -6.1702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2799 -10.9654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5325 -11.1683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1085 -10.3489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 5 1 0
3 1 1 0
4 3 2 0
5 1 1 0
6 10 1 0
7 2 2 0
8 6 2 0
9 5 2 0
10 13 1 0
11 12 2 0
12 9 1 0
13 14 1 0
14 4 1 0
15 6 1 0
4 2 1 0
7 11 1 0
1 16 1 0
9 17 1 0
12 18 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 244.34 | Molecular Weight (Monoisotopic): 244.1576 | AlogP: 2.47 | #Rotatable Bonds: 3 |
Polar Surface Area: 34.03 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.56 | CX LogD: 2.56 |
Aromatic Rings: 2 | Heavy Atoms: 18 | QED Weighted: 0.88 | Np Likeness Score: -0.86 |
References
1. Zaryanova EV, Lozinskaya NA, Beznos OV, Volkova MS, Chesnokova NB, Zefirov NS.. (2017) Oxindole-based intraocular pressure reducing agents., 27 (16): [PMID:28687205] [10.1016/j.bmcl.2017.06.065] |